Chadalavada Venkat

Chadalavada Venkat

Director Director DIN 06541925
DIN 06541925 First appointment Mar 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2013
Shareholding value •••• Premium profile

About Chadalavada Venkat

Data last updated:

Chadalavada Venkat was a Director at Alchemy Medicine Private Limited (2019–2023) and Director at Maysa Labs Private Limited (2013–2020). The companies operate in Pharma.

DIN 06541925
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alchemy Medicine Private Limited U24100DL2009PTC195559
Director04 Nov 20192009₹24.15 Cr (FY 2025)Active
Maysa Labs Private Limited U24233TG2013PTC086517
Director29 Mar 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alchemy Medicine Private Limited
Maysa Labs Private Limited
Premium access

Shareholding and investment profile for Chadalavada Venkat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chadalavada Venkat

Chadalavada Venkat was first appointed on 29 Mar 2013 as Director at Maysa Labs Private Limited. The most recent appointment on record is 04 Nov 2019 at Alchemy Medicine Private Limited.

Chadalavada Venkat held 2 earlier board appointments: Alchemy Medicine Private Limited (Director, 04 Nov 2019 to 30 Oct 2023); Maysa Labs Private Limited (Director, 29 Mar 2013 to 05 Jun 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available